(19)
(11) EP 2 491 973 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
23.11.2016 Bulletin 2016/47

(45) Mention of the grant of the patent:
31.08.2016 Bulletin 2016/35

(21) Application number: 12162709.5

(22) Date of filing: 08.06.2006
(51) International Patent Classification (IPC): 
A61M 29/02(2006.01)
A61B 17/3207(2006.01)
A61B 34/20(2016.01)
A61M 25/10(2006.01)
 A61B 17/24(2006.01)
A61M 25/06(2006.01)
A61M 25/00(2006.01)

(54)

Systems useable for treating sinusitis

Systeme zur Behandlung von Stirnhöhlenentzündung

Systemes permettant de traiter une sinusite

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

(30) Priority: 10.06.2005 US 150847

(43) Date of publication of application:
29.08.2012 Bulletin 2012/35

(62) Application number of the earlier application in accordance with Art. 76 EPC:
06784759.0 / 1896113

(73) Proprietor: Acclarent, Inc.
Irvine, CA 92618 (US)

(72) Inventors:
  • Chang, John Y.
    Los Altos, CA 94022 (US)
  • Makower, Joshua
    Los Altos, CA 94022 (US)
  • Vrany, Julia D.
    Sunnyvale, CA 94086 (US)
  • Morriss, John H.
    Portola Valley, CA 94028 (US)
  • Muni, Ketan P.
    San Jose, CA 95123 (US)
  • Kim, Isaac J.
    San Jose, CA 92132 (US)
  • Ha, Hung
    San Jose, CA 95135 (US)
  • Facteau, William M.
    Mountain View, CA 94041 (US)
  • Walke, Amrish Jayprakash
    Milpitas, CA 95035 (US)

(74) Representative: Carpmaels & Ransford LLP 
One Southampton Row
London WC1B 5HA
London WC1B 5HA (GB)


(56) References cited: : 
US-A- 5 269 752
US-A- 5 775 327
US-A1- 2006 063 973
 US-A- 5 507 766
US-A1- 2005 107 738
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).